Guideline Summary of Bisphosphonates and ONJ
Friday, September 24, 2010
Osteoporosis Australia and the Australian Dental Association (through the Dental Therapeutics Committee) have prepared a joint Information Sheet that provides advice to practitioners on the use of Bisphosphonates.
The information sheet provides up to date pertinent information that will assist both medical and dental practitioners in the use of Bisphosphonates. The Information Sheet is commended by the ADA’s Dental Therapeutics Committee as essential reading for dental practitioners.
The Information Sheet deals with the following issues:
What is osteoporosis?
How is osteoporosis treated?
What are the side effects of the bisphosphonates?
What is the incidence of ONJ and who is at risk?
What should you do if your patient requires an extraction whilst they are taking bisphosphonates?
What can doctors do to try to prevent ONJ?
What should you do if a patient requires an extraction?
What are the risks for patients using intravenous bisphosphonates?
How should established ONJ be treated?
Is ONJ more likely to occur in cancer patients?
Copies of the joint Information Sheet are available for perusal and downloading below:
+ ADA and OA Information Sheet on Bisphosphonates and ONJ